Page last updated: 2024-10-17

aminocaproic acid and Bilirubinemia

aminocaproic acid has been researched along with Bilirubinemia in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research Excerpts

ExcerptRelevanceReference
"The prolonged administration of epsilon-aminocaproic acid (EACA) resulted in the development of severe proximal myopathy associated with high plasma creatine kinase values, rhabdomyolysis, myoglobinuria, and mild hyperbilirubinaemia."3.66Epsilon-aminocaproic acid-induced myopathy. A case report. ( Berman, PA; Jacobs, P; Morris, CD; Rutherfoord, GS, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morris, CD1
Jacobs, P1
Berman, PA1
Rutherfoord, GS1

Other Studies

1 other study available for aminocaproic acid and Bilirubinemia

ArticleYear
Epsilon-aminocaproic acid-induced myopathy. A case report.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1983, Sep-03, Volume: 64, Issue:10

    Topics: Adult; Aminocaproates; Aminocaproic Acid; Animals; Cathepsin D; Cathepsins; Creatine Kinase; Female;

1983